Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Living Close to Natural Outdoor Environments in Four European Cities: Adults' Contact with the Environments and Physical Activity.
Triguero-Mas M, Donaire-Gonzalez D, Seto E, Valentín A, Smith G, Martínez D, Carrasco-Turigas G, Masterson D, van den Berg M, Ambròs A, Martínez-Íñiguez T, Dedele A, Hurst G, Ellis N, Grazulevicius T, Voorsmit M, Cirach M, Cirac-Claveras J, Swart W, Clasquin E, Maas J, Wendel-Vos W, Jerrett M, Gražulevičienė R, Kruize H, Gidlow CJ, Nieuwenhuijsen MJ. Triguero-Mas M, et al. Among authors: clasquin e. Int J Environ Res Public Health. 2017 Sep 30;14(10):1162. doi: 10.3390/ijerph14101162. Int J Environ Res Public Health. 2017. PMID: 28974010 Free PMC article.
Natural outdoor environments and mental health: Stress as a possible mechanism.
Triguero-Mas M, Donaire-Gonzalez D, Seto E, Valentín A, Martínez D, Smith G, Hurst G, Carrasco-Turigas G, Masterson D, van den Berg M, Ambròs A, Martínez-Íñiguez T, Dedele A, Ellis N, Grazulevicius T, Voorsmit M, Cirach M, Cirac-Claveras J, Swart W, Clasquin E, Ruijsbroek A, Maas J, Jerret M, Gražulevičienė R, Kruize H, Gidlow CJ, Nieuwenhuijsen MJ. Triguero-Mas M, et al. Among authors: clasquin e. Environ Res. 2017 Nov;159:629-638. doi: 10.1016/j.envres.2017.08.048. Epub 2017 Sep 19. Environ Res. 2017. PMID: 28938204
Histological Outcomes And Jak-Stat Signalling In Ulcerative Colitis Patients Treated With Tofacitinib.
van Gennep S, Fung ICN, de Jong DC, Ramkisoen RK, Clasquin E, de Jong J, de Vries LCS, de Jonge WJ, Gecse KB, Löwenberg M, Woolcott JC, Mookhoek A, D'Haens GR. van Gennep S, et al. Among authors: clasquin e. J Crohns Colitis. 2024 Mar 20:jjae031. doi: 10.1093/ecco-jcc/jjae031. Online ahead of print. J Crohns Colitis. 2024. PMID: 38506097 Free article.
Early versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes.
Vermeire S, Hanzel J, Löwenberg M, Ferrante M, Bossuyt P, Hoentjen F, Franchimont D, Palatka K, Peeters H, Mookhoek A, de Hertogh G, Molnár T, van Moerkercke W, Lobatón T, Clasquin E, Hulshoff MS, Baert F, D'Haens G; LOVE-UC study group. Vermeire S, et al. Among authors: clasquin e. J Crohns Colitis. 2023 Nov 2:jjad179. doi: 10.1093/ecco-jcc/jjad179. Online ahead of print. J Crohns Colitis. 2023. PMID: 37934813
Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial.
Löwenberg M, Volkers A, van Gennep S, Mookhoek A, Montazeri N, Clasquin E, Duijvestein M, van Bodegraven A, Rietdijk S, Jansen J, van Asseldonk D, van der Zanden E, Dijkgraaf M, West R, de Boer N, D'Haens G. Löwenberg M, et al. Among authors: clasquin e. J Crohns Colitis. 2023 Jul 5;17(7):1055-1065. doi: 10.1093/ecco-jcc/jjad022. J Crohns Colitis. 2023. PMID: 36847130 Free PMC article. Clinical Trial.
Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study.
Hanzel J, Dreesen E, Vermeire S, Löwenberg M, Hoentjen F, Bossuyt P, Clasquin E, Baert FJ, D'Haens GR, Mathôt R. Hanzel J, et al. Among authors: clasquin e. Inflamm Bowel Dis. 2022 May 4;28(5):817. doi: 10.1093/ibd/izab270. Inflamm Bowel Dis. 2022. PMID: 34788812 Free PMC article. No abstract available.
High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn's Disease in a Randomized Placebo-Controlled Trial.
de Bruyn JR, Bossuyt P, Ferrante M, West RL, Dijkstra G, Witteman BJ, Wildenberg M, Hoentjen F, Franchimont D, Clasquin E, van der Bilt JD, Tollens T, Bemelman WA, D'Hoore A, Duijvestein M, D'Haens GR; Dutch-Belgian The Effect of Vitamin D3 to Prevent Postoperative Relapse of Crohn’s Disease: A Placebo-controlled Randomized Trial Study Group. de Bruyn JR, et al. Among authors: clasquin e. Clin Gastroenterol Hepatol. 2021 Aug;19(8):1573-1582.e5. doi: 10.1016/j.cgh.2020.05.037. Epub 2020 May 24. Clin Gastroenterol Hepatol. 2021. PMID: 32461138 Free article. Clinical Trial.
Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
Löwenberg M, Vermeire S, Mostafavi N, Hoentjen F, Franchimont D, Bossuyt P, Hindryckx P, Rispens T, de Vries A, van der Woude CJ, Berends S, Ambarus CA, Mathot R, Clasquin E, Baert F, D'Haens G. Löwenberg M, et al. Among authors: clasquin e. Gastroenterology. 2019 Oct;157(4):997-1006.e6. doi: 10.1053/j.gastro.2019.05.067. Epub 2019 Jun 5. Gastroenterology. 2019. PMID: 31175865